Cedars-Sinai Medical Center in Los Angeles is the focus of a U.S. Food and Drug Administration investigation into more than 200 cases of overexposure to radiation during CT brain perfusion studies.
FDA CT overdose probe focuses on Cedars-Sinai
Oct 12, 2009
Latest in CT
Lung-RADS may speed diagnosis of cystic airspace lung cancer
November 10, 2026
Deep-learning model predicts mortality from CTA scans
November 6, 2026
Detection Technology launches new CT detector module
November 4, 2026


















